100 related articles for article (PubMed ID: 16413684)
1. Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhanced.
Wiseman A
Med Hypotheses; 2006; 66(5):1046-7. PubMed ID: 16413684
[No Abstract] [Full Text] [Related]
2. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
[TBL] [Abstract][Full Text] [Related]
3. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
Habel ME; Lemieux R; Jung D
J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein.
Fest T; Guffei A; Williams G; Silva S; Mai S
Oncogene; 2005 Apr; 24(18):2944-53. PubMed ID: 15735723
[TBL] [Abstract][Full Text] [Related]
5. Cancer: two in one.
Berns A
Nature; 2005 Aug; 436(7052):787-9. PubMed ID: 16094355
[No Abstract] [Full Text] [Related]
6. c-myc Suppression in Burkitt's lymphoma cells.
Simonsson T; Henriksson M
Biochem Biophys Res Commun; 2002 Jan; 290(1):11-5. PubMed ID: 11779125
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
8. High expression of apoptosis-regulating proteins in Burkitt's lymphomas.
Pagnano KB; Silva MD; Vassallo J; Souza MS; Costa FF; Saad ST
Haematologica; 2002 Mar; 87(3):ELT16. PubMed ID: 11869962
[No Abstract] [Full Text] [Related]
9. Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression.
Suk FM; Lin SY; Lin RJ; Hsine YH; Liao YJ; Fang SU; Liang YC
Oncotarget; 2015 Sep; 6(28):25988-6001. PubMed ID: 26317903
[TBL] [Abstract][Full Text] [Related]
10. The great MYC escape in tumorigenesis.
Dang CV; O'donnell KA; Juopperi T
Cancer Cell; 2005 Sep; 8(3):177-8. PubMed ID: 16169462
[TBL] [Abstract][Full Text] [Related]
11. Long term follow-up of c-myc, p53 and proliferation measurements in malignant melanoma.
Ross DA; Laing JH; Sanders R; Wilson GD
Eur J Surg Oncol; 2006 Feb; 32(1):80-4. PubMed ID: 16256294
[TBL] [Abstract][Full Text] [Related]
12. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.
Cardone M; Kandilci A; Carella C; Nilsson JA; Brennan JA; Sirma S; Ozbek U; Boyd K; Cleveland JL; Grosveld GC
Mol Cell Biol; 2005 Mar; 25(6):2395-405. PubMed ID: 15743832
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
[TBL] [Abstract][Full Text] [Related]
14. c-Myc over-expression in Ramos Burkitt's lymphoma cell line predisposes to iron homeostasis disruption in vitro.
Habel ME; Jung D
Biochem Biophys Res Commun; 2006 Mar; 341(4):1309-16. PubMed ID: 16466700
[TBL] [Abstract][Full Text] [Related]
15. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
Kuttler F; Amé P; Clark H; Haughey C; Mougin C; Cahn JY; Dang CV; Raffeld M; Fest T
Oncogene; 2001 Sep; 20(42):6084-94. PubMed ID: 11593416
[TBL] [Abstract][Full Text] [Related]
16. Modeling the therapeutic efficacy of p53 restoration in tumors.
Martins CP; Brown-Swigart L; Evan GI
Cell; 2006 Dec; 127(7):1323-34. PubMed ID: 17182091
[TBL] [Abstract][Full Text] [Related]
17. Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma.
Hartleben G; Müller C; Krämer A; Schimmel H; Zidek LM; Dornblut C; Winkler R; Eichwald S; Kortman G; Kosan C; Kluiver J; Petersen I; van den Berg A; Wang ZQ; Calkhoven CF
EMBO J; 2018 Nov; 37(21):. PubMed ID: 30237309
[TBL] [Abstract][Full Text] [Related]
18. Cancer regression by senescence.
Serrano M
N Engl J Med; 2007 May; 356(19):1996-7. PubMed ID: 17494935
[No Abstract] [Full Text] [Related]
19. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
Gregory MA; Hann SR
Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
[TBL] [Abstract][Full Text] [Related]
20. Emerging molecular networks in Burkitt's lymphoma.
Mangani D; Roberti A; Rizzolio F; Giordano A
J Cell Biochem; 2013 Jan; 114(1):35-8. PubMed ID: 22903691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
